PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.46%
Revenue growth 1.25-1.5x ADI's 13.18%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
25.99%
Gross profit growth 1.25-1.5x ADI's 18.88%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
51.31%
EBIT growth above 1.5x ADI's 21.85%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
54.85%
Operating income growth above 1.5x ADI's 21.85%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
29.41%
Net income growth comparable to ADI's 30.77%. Walter Schloss might see both following similar market or cost trajectories.
31.25%
EPS growth above 1.5x ADI's 20.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
25.00%
Diluted EPS growth 1.25-1.5x ADI's 22.22%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.26%
Share reduction more than 1.5x ADI's 11.71%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.57%
Diluted share reduction more than 1.5x ADI's 8.78%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
2.76%
Dividend growth of 2.76% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
42.40%
Similar OCF growth to ADI's 44.35%. Walter Schloss would assume comparable operations or industry factors.
260.00%
FCF growth above 1.5x ADI's 53.15%. David Dodd would verify if the firm’s strategic investments yield superior returns.
18.29%
10Y revenue/share CAGR under 50% of ADI's 125.77%. Michael Burry would suspect a lasting competitive disadvantage.
-12.42%
Negative 5Y CAGR while ADI stands at 63.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-5.56%
Negative 3Y CAGR while ADI stands at 13.62%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-2.54%
Negative 5Y OCF/share CAGR while ADI is at 44.47%. Joel Greenblatt would question the firm’s operational model or cost structure.
77.15%
3Y OCF/share CAGR under 50% of ADI's 577.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
150.39%
Net income/share CAGR at 75-90% of ADI's 192.64%. Bill Ackman would press for strategic moves to boost long-term earnings.
64.61%
5Y net income/share CAGR at 50-75% of ADI's 101.40%. Martin Whitman might see a shortfall in operational efficiency or brand power.
310.75%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
130.52%
5Y equity/share CAGR at 50-75% of ADI's 183.55%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
48.58%
3Y equity/share CAGR at 50-75% of ADI's 95.62%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
88.55%
Dividend/share CAGR of 88.55% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
83.56%
Dividend/share CAGR of 83.56% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-0.18%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
18.90%
AR growth well above ADI's 5.33%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.49%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.61%
Negative asset growth while ADI invests at 2.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.37%
Under 50% of ADI's 10.71%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
17.36%
R&D growth drastically higher vs. ADI's 17.68%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
4.02%
SG&A growth well above ADI's 6.49%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.